Skip to content
Search

Latest Stories

Pharmacist Support seeks 2 dedicated trustees to expand impact

Pharmacist Support seeks 2 dedicated trustees to expand impact
The pharmacist charity values diversity and encourages individuals of all backgrounds to apply for trustee positions

In a recent announcement, the independent charity for pharmacy profession, Pharmacist Support, is seeking to recruit 2 new trustees to its board as it embarks on a new five- year strategy.

The new members on the board of trustees will be providing strategic direction and leadership to Pharmacist Support family committed to fostering equality, valuing diversity, and an inclusive environment for all stakeholders.


With a focus on fostering personal and professional growth while supporting the pharmacy community, the charity provides services including financial assistance, addiction support, and more.

Pharmacist Support chief executive Danielle Hunt called the opportunity as an ideal one for "pharmacists who want to support our 'pharmacy family' while developing their personal and professional skills."

Over the years, Pharmacist Support has significantly broadened its outreach and impact, particularly in addressing critical issues like mental health and wellbeing within the profession.

Recently, the pharmacy charity marked a significant milestone by announcing a formal agreement with the Royal Pharmaceutical Society(RPS) to enhance collaboration to better support RPS members and increase the impact of the charity.

The addition of new trustees is expected to further amplify the charity's efforts in growth and development.

"We value 'lived' experience over previous board or trustee roles, as comprehensive training will be provided," emphasises Hunt.

"The time commitment for this role is approximately one day per month, including in-person quarterly board meetings and quarterly online sub-committee meetings, and we offer flexibility to accommodate personal availability."

Pharmacist Support is committed to assembling a diverse and inclusive Board of Trustees, welcoming individuals from varied backgrounds and levels of experience.

Essential qualities include a fervent dedication to the charity's mission and a genuine desire to effect positive change.

Applications close on 7th June 2024, with interviews scheduled for 8th July 2024 in Manchester. Interested candidates to share their CV and cover letters at recruit@pharmacistsupport.org. Visit the website for further information.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less